Organoid Therapeutics
Organoid Therapeutics develops and delivers organoid-based artificial organ technologies for the treatment of diabetes and other disorders.
Organoid Therapeutics is active in the biotechnology, health care, medical, pharmaceutical space based in Great Lakes, Northeastern US, founded in 2019.
Within the biotechnology, health care, medical, pharmaceutical space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in Great Lakes, Northeastern US.
It is recorded at the Private company stage.
The company reports a headcount in the c_00001_00010 range.
| Sector | Biotechnology, Health Care, Medical, Pharmaceutical |
|---|---|
| Headquarters | Great Lakes, Northeastern US |
| Founded | 2019 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: organoidtherapeutics.co
Browse related
Sign in to view the contact information we hold for Organoid Therapeutics.
Create a free account
Create a free account